Project Grant HT94252310637
Award Date
9/15/23
Completion Date
9/14/25
Dollars Obligated
$708K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
This federal Project Grant award for $704,000.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the Sloan-Kettering Institute for Cancer Research in New York, NY. The research aims to investigate the role of the NF-I/A transcription factor in regulating fatty acid metabolism in kidney cancer. This multi-year project will run from September 1, 2024 to August 31, 2028. As the prime grantee, the Sloan-Kettering...
This federal Project Grant award of $2,808,108.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the Sloan-Kettering Institute for Cancer Research to investigate the role of clonal hematopoiesis in therapeutic resistance and metastatic relapse in breast cancer. The award period extends from March 1, 2024 to February 29, 2028. Through this funding, the Sloan-Kettering Institute will explore the...
The Defense Health Agency awarded a $923,805 Project Grant to the Sloan-Kettering Institute for Cancer Research in New York, NY under the Military Medical Research and Development program (CFDA 12.420). The grant supports a 3-year research project titled "Systematic Functional Dissection of Cancer Cell States in Lung Tumors" starting on September 1, 2025. Through this funding, the Sloan-Kettering Institute will conduct advanced biomedical research focused on transforming healthcare for...
The federal Project Grant award, valued at $1,944,610.00 and effective from April 1, 2025 to March 31, 2028, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The primary awardee, Sloan-Kettering Institute for Cancer Research, will conduct research to understand tumorigenesis and identify therapeutic targets in CDK12-mutant prostate cancer. This work will involve collaboration with The University of Texas MD Anderson Cancer...
The Sloan-Kettering Institute for Cancer Research was awarded a $707,437 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2025 to enhance the immunogenicity of nectin-4 targeted therapy for the treatment of aggressive bladder cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
The Defense Health Agency awarded a $352,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to the Sloan-Kettering Institute for Cancer Research. The grant, titled "AUGMENTING IN VIVO EFFICACY OF A NOVEL LANOSTEROL SYNTHASE INHIBITOR IN GLIOBLASTOMA," will support advanced biomedical research focused on transforming healthcare for military service members and the broader public. The research aims to develop innovative approaches to...
The Defense Health Agency awarded a $619,500 Project Grant to the Sloan-Kettering Institute for Cancer Research, a non-profit organization in New York, NY. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program and will support research to investigate the immunogenicity and targeting of shared neoantigens in adenoid cystic cancer over a 3-year period from September 1, 2023 to August 31, 2026. The research aims to transform health care for Service...
Sloan-Kettering Institute For Cancer Research was awarded a $845,789 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2023 to June 30, 2026. The grant will support research to discover biomarkers and address outcome disparities for prostate cancer through exploiting real-world clinical genomic data. As the prime recipient, Sloan-Kettering Institute For Cancer Research will leverage its expertise...
The federal Project Grant award of $924,001.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the Sloan-Kettering Institute for Cancer Research to investigate the cellular and molecular origins of non-small cell lung cancer (NSCLC) brain metastasis. The research aims to enhance understanding of the mechanisms driving NSCLC brain metastasis, with the goal of developing innovative therapeutic...
The federal Project Grant award of $924,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports research conducted by the Sloan-Kettering Institute for Cancer Research in New York, NY to investigate "Therapeutic Strategies for Targeting Diverse KRAS Mutations in Lung Cancer". The research aims to advance disease prevention, diagnosis, treatment, and management of lung cancer through...